Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash from Investing (TTM): -68.76M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -68.76M |
| June 30, 2023 | -91.14M |
| March 31, 2023 | -42.36M |
| December 31, 2022 | -117.29M |
| Date | Value |
|---|---|
| September 30, 2022 | -106.16M |
| June 30, 2022 | -93.86M |
| March 31, 2022 | -90.70M |
| December 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-117.29M
Minimum
Dec 2022
--
Maximum
Dec 2021
-76.28M
Average
-90.92M
Median
Cash from Investing (TTM) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -160.32M |
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.41M |
| iBio Inc | 1.044M |
| Theriva Biologics Inc | -0.194M |